Used in research for treating cancers, particularly those driven by MET and other receptor tyrosine kinase pathways. It acts as a potent inhibitor, blocking abnormal signaling in tumor cells to suppress growth and proliferation. Shows activity in preclinical models against various solid tumors, including lung and gastric cancers with MET amplification or mutation. Investigated for overcoming resistance to other targeted therapies. Not approved for clinical use; strictly for laboratory research.